Immunic AG | Finanzwire

Basculer en Français

10229	Companies
211144	Keywords
141063	Articles
111850	Press releases

Home
Companies
Immunic AG

BRIEF

published on 04/09/2026 at 12:35, 7 days 10 hours ago

Immunic to Engage in Key Scientific Conferences in April

Biotechnology Clinical Trials Conférences Oral Therapies Neurology
PRESS RELEASE

published on 04/09/2026 at 12:30, 7 days 10 hours ago

Immunic to Participate in Scientific and Medical Conferences in April
Immunic, Inc. to participate in scientific and medical conferences in April. Presentation on vidofludimus calcium for treating multiple sclerosis at the Neuroimmunology Drug Development Summit and AAN Annual Meeting

Immunic Inc. Multiple Sclerosis Vidofludimus Calcium Scientific Conferences Medical Conferences
BRIEF

published on 04/01/2026 at 12:35, 15 days 10 hours ago

Immunic Achieves Nasdaq Compliance

Biotechnology Nasdaq Compliance Stock Market Immunic Neurologic Therapies
PRESS RELEASE

published on 04/01/2026 at 12:30, 15 days 10 hours ago

Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement
Immunic regains compliance with Nasdaq minimum bid price requirement. The company's common stock closed at $1.00 per share or greater for 20 consecutive business days

Compliance Nasdaq Immunic Minimum Bid Price Neurologic Diseases
BRIEF

published on 03/31/2026 at 12:35, 16 days 10 hours ago

Immunic Appoints Jon Congleton to Board of Directors

Board Of Directors Biopharmaceutical Multiple Sclerosis Immunic Jon Congleton
PRESS RELEASE

published on 03/31/2026 at 12:30, 16 days 10 hours ago

Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton
Immunic strengthens its Board of Directors with the appointment of seasoned biopharmaceutical executive Jon Congleton on March 31, 2026, to support the development of novel oral therapies for neurologic diseases

Board Of Directors Biopharmaceutical Immunic Neurologic Diseases Jon Congleton
BRIEF

published on 03/10/2026 at 11:35, 1 month 6 days ago

Immunic Secures European Patent for Vidofludimus Calcium Dosing

Intellectual Property Multiple Sclerosis Immunic Vidofludimus Calcium European Patent
PRESS RELEASE

published on 03/10/2026 at 11:30, 1 month 6 days ago

Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
Immunic AG announces grant of key European patent protecting relevant dosing regimens for vidofludimus calcium, strengthening global intellectual property strategy

Intellectual Property Vidofludimus Calcium Immunic AG European Patent Dosing Regimens
BRIEF

published on 03/03/2026 at 12:35, 1 month 13 days ago

Immunic to Attend Key Investor Conferences in March

Biotechnology Investor Conferences Immunic Gastrointestinal Disorders Neurologic Diseases
PRESS RELEASE

published on 03/03/2026 at 12:30, 1 month 13 days ago

Immunic to Participate in Investor Conferences in March
Immunic, Inc. (Nasdaq: IMUX) to participate in investor conferences in March, including Leerink Partners Global Healthcare Conference and Stifel 2026 Virtual CNS Forum. Leading late-stage biotechnology company developing novel oral therapies

Biotechnology Investor Conferences Clinical Trials Immunic Inc. Oral Therapies

Accesswire

Published on 04/16/2026 at 21:30, 1 hour 24 minutes ago

Organto Foods Expands Financing Facilities with Rabobank
Published on 04/16/2026 at 15:55, 6 hours 59 minutes ago

TripSitter Announces Director Resignation
Published on 04/16/2026 at 15:20, 7 hours 34 minutes ago

Datavault AI Goes Live with First Edge GPU Sites in New York and Philadelphia; $1.44B-$1.92B Quantum-Ready Fleet to Reach 100+ U.S. Cities by End of 2026
Published on 04/16/2026 at 15:00, 7 hours 54 minutes ago

FaZe Esports, a GameSquare Company, Announces Partnership with CORSAIR
Published on 04/16/2026 at 14:44, 8 hours 10 minutes ago

Worksport to Showcase SOLIS(TM), COR(TM) and Expanded Product Line at the 2026 MOORE Overlanding Expo

View all ACCESSWIRE

EQS Group

Published on 04/16/2026 at 21:37, 1 hour 16 minutes ago

Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.
Published on 04/16/2026 at 21:00, 1 hour 53 minutes ago

Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment
Published on 04/16/2026 at 20:35, 2 hours 18 minutes ago

EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 3 hours 36 minutes ago

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 18:57, 3 hours 57 minutes ago

Op-Ed: Africa’s Energy Wealth: Why Good Governance Must Power a Just Transition (By Sola Adebawo)

Les Echos

Published on 04/16/2026 at 18:02, 4 hours 52 minutes ago

Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 18:00, 4 hours 54 minutes ago

ICADE – PR – Q1 2026 TRADING UPDATE
Published on 04/16/2026 at 17:55, 4 hours 58 minutes ago

Publication of 2026 1st quarter turnover
Published on 04/16/2026 at 17:54, 5 hours ago

Aéroports de Paris S.A - March 2026 traffic figures
Published on 04/16/2026 at 17:45, 5 hours 9 minutes ago

VOGO : 2025 full-year results.

View all LES ECHOS COMFI WIRE